Comment on Bordeleau et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366
- PMID: 25249682
- DOI: 10.2337/dc14-1380
Comment on Bordeleau et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366
Comment in
-
Response to Zanders et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366.Diabetes Care. 2014 Oct;37(10):e223. doi: 10.2337/dc14-1567. Diabetes Care. 2014. PMID: 25249683 No abstract available.
Comment on
-
The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia.Diabetes Care. 2014;37(5):1360-6. doi: 10.2337/dc13-1468. Epub 2014 Feb 26. Diabetes Care. 2014. PMID: 24574355 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical